add_action('wp_footer', function () { ?>

Full description:

  • Denk-Air Junior 4 mg is a medicine that blocks the binding of certain inflammatory mediators (leukotrienes).
  • Leukotrienes cause narrowing and swelling of the airways in the lungs. By blocking the leukotrienes, Denk-Air Junior 4 mg alleviates the symptoms of asthma, and helps to control asthma.

What Denk-Air 4 mg contains:

  • The active substance is montelukast. Each chewable tablet contains 4 mg montelukast (as montelukast sodium).
  • The other ingredients are mannitol, microcrystalline cellulose, hydroxypropyl cellulose, iron oxide red, croscarmellose sodium, cherry flavour (contains: flavouring substances, arabic gum, maltodextrin, propylene glycol), aspartame, magnesium stearate [vegetable].

Possible side effects:

Like all medicines, this medicine can cause side effects, although not everybody gets them. In clinical studies with montelukast 4 mg chewable tablets, the most commonly reported side effects (may affect up to 1 in 10 people) thought to be related to montelukast were:

  • abdominal pain
  • thirst.

Additionally, the following side effect was reported in clinical studies with montelukast 10 mg film- coated tablets and 5 mg chewable tablets:

  • headache.

These were usually mild and occurred at a greater frequency in patients treated with montelukast than placebo (a pill containing no medication).

Serious side effects

Talk with your doctor immediately if you notice any of the following side effects, which may be serious, and for which you may need urgent medical treatment.

Uncommon (may affect up to 1 in 100 people)

  • allergic reactions including swelling of the face, lips, tongue, and/or throat which may cause difficulty in breathing or swallowing
  • behaviour and mood related changes: agitation including aggressive behaviour or hostility, depression
  • seizure

Rare (may affect up to 1 in 1,000 people)

  • increased bleeding tendency
  • tremor
  • palpitations
  • Very rare (may affect up to 1 in 10,000 people)
  • combination of symptoms such as flu-like illness, pins and needles or numbness of arms and legs, worsening of pulmonary symptoms and/or rash (Churg-Strauss syndrome) (see section 2)
  • low blood platelet count
  • behaviour and mood related changes: hallucinations, disorientation, suicidal thoughts and actions
  • swelling (inflammation) of the lungs
  • severe skin reactions (erythema multiforme) that may occur without warning
  • inflammation of the liver (hepatitis)
  • Other side effects while the medicine has been on the market
  • Very common (may affect more than 1 in 10 people)
  • upper respiratory infection
  • Common (may affect up to 1 in 10 people)
  • diarrhoea, nausea, vomiting
  • rash
  • fever
  • elevated liver enzymes
  • Uncommon (may affect up to 1 in 100 people)
  • behaviour and mood related changes: dream abnormalities, including nightmares, trouble sleeping, sleepwalking, irritability, feeling anxious, restlessness
  • dizziness, drowsiness, pins and needles/numbness
  • nosebleed
  • dry mouth, indigestion
  • bruising, itching, hives
  • joint or muscle pain, muscle cramps
  • bedwetting in children
  • weakness/tiredness, feeling unwell, swelling
  • Rare (may affect up to 1 in 1,000 people)
  • behaviour and mood related changes: disturbance in attention, memory impairment, uncontrolled muscle movements
  • Very rare (may affect up to 1 in 10,000 people)
  • tender red lumps under the skin, most commonly on your shins (erythema nodosum)
  • behavior and mood related changes: obsessive-compulsive symptoms
  • stuttering
  • How to take:
  • Always have your child take this medicine exactly as your doctor or pharmacist has told you. Check with your child’s doctor or pharmacist if you are not sure.
  • This medicine is to be given to a child under adult supervision.
  • Your child should take only one chewable tablet of Denk-Air Junior 4 mg once a day as prescribed by your doctor.
  • Continue giving your child this medicine even if there are no further symptoms.
  • Do not interrupt treatment in the event of an acute asthma attack.
Status

რეცეფტული

ამ პროდუქტის დეტალები არ არის ხელმისაწვდომი.